Government News

Total 36 different medical devices are manufactured under Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices in India. These medical devices belong to different portfolios such as Imaging & Diagnostics, Critical Care & Emergency, Interventional CardioVascular, Renal Care Devices, Orthopaedic Implants, Oncology and specialist divisions.

Target set to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027.

The Central Drugs Standard Control Organization (CDSCO) has issued a directive to all State and Union Territory Drug Controllers, stressing the need for strict compliance with the Drugs Rules, 1945, in testing raw materials and finished pharmaceutical formulations.

World Health Organization, WHO has released updated editions of its Model Lists of Essential Medicines and Essential Medicines for Children, adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.

The Ministry of Health & Family Welfare through National Rabies Control Program (NRCP) is undertaking strengthening of surveillance of all animal bites in all States/UTs. Data on dog and other animal bite cases and related deaths are reported by all States/UTs, through Integrated Health Information Platform

Shri Amit Agrawal, Secretary, Department of Pharmaceuticals, highlighted Indias transformation into an emerging hub for medical technology at the 17th CII Global MedTech Summit, themed Innovating for a Healthier Future – Advancing MedTech for Global Impact: Make in India, Make for the World, in New Delhi.

The Subject Expert Committee Oncology, in its 25th meeting held at CDSCO headquarters, has recommended granting permission to Bayer Pharmaceuticals Pvt. Ltd. for the manufacture and marketing of Darolutamide Film-Coated Tablets 300 mg in India.

The Government of India is accelerating its efforts to reduce dependence on pharmaceutical imports and strengthen domestic capabilities, with the Department of Pharmaceuticals rolling out key initiatives and reporting remarkable progress under flagship schemes.

Over the past few years, Department of Atomic Energy (DAE) has developed several key nuclear medicine ligands and targeted therapeutics towards national effort against cancer, especially in the areas of advanced treatment and research. To cater the demand for import substitute radiation-medicine in India, Department of Atomic Energy